Skip to content
RIDAURA

Drawing based on the label description. No photo yet.

RIDAURA pill

Pill with imprint RIDAURA is brown, capsule, 14 mm and has been identified as Auranofin 3 mg. It is used for rheumatoid arthritis, pemphigus and psoriatic arthritis. It is supplied by Prometheus Laboratories Inc.

Auranofin 3 mg

Imprint
RIDAURA
Strength
3 mg
Used for
Rheumatoid arthritis, pemphigus and psoriatic arthritis
Color
Brown
Shape
Capsule / oblong
Size
14 mm
Score
No score line
Form
Capsule
Manufacturer
Prometheus Laboratories Inc
NDC
65483-093, 65483-093-06, 54766-093, 54766-093-06, 85437-093, 85437-093-06

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Auranofin pills and guides

What is Auranofin used for?

Auranofin is used for rheumatoid arthritis, pemphigus and psoriatic arthritis.

Official uses from the US prescribing label

RIDAURA (auranofin) is indicated in the management of adults with active classical or definite rheumatoid arthritis (ARA criteria) who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs. RIDAURA should be added to a comprehensive baseline program, including non-drug therapies.

Unlike anti-inflammatory drugs, RIDAURA does not produce an immediate response. Therapeutic effects may be seen after three to four months of treatment, although improvement has not been seen in some patients before six months.

When cartilage and bone damage has already occurred, gold cannot reverse structural damage to joints caused by previous disease. The greatest potential benefit occurs in patients with active synovitis, particularly in its early stage.

In controlled clinical trials comparing RIDAURA with injectable gold, RIDAURA was associated with fewer dropouts due to adverse reactions, while injectable gold was associated with fewer dropouts for inadequate or poor therapeutic effect. Physicians should consider these findings when deciding on the use of RIDAURA in patients who are candidates for chrysotherapy.

From the FDA-approved label on DailyMed (published Nov 17, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows RIDAURA.
  • It is brown, capsule, 14 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Ridaura.

Ingredients

Active: Auranofin

Inactive: Benzyl Alcohol, Cellulose, Microcrystalline, Cetylpyridinium Chloride, D&c Red No. 33, Fd&c Blue No. 1, Fd&c Red No. 40, Fd&c Yellow No. 6, Gelatin, Lactose, Magnesium Stearate, Povidone, Sodium Lauryl Sulfate, Sodium Starch Glycolate Type A Potato, Starch, Corn, Titanium Dioxide

Also distributed by

Sebela Pharmaceuticals Inc., Coral Way Pharma, LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Auranofin pills